metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Prevalence, risk factors for and trends in faecal colonisation by extended-spect...
Journal Information
Share
Share
Download PDF
More article options
Visits
166
Original article
Available online 10 December 2024
Prevalence, risk factors for and trends in faecal colonisation by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) in the community in Spain: A cross-sectional study and meta-analysis
Prevalencia, factores de riesgo y tendencias en la colonización fecal por Enterobacterales productores de beta-lactamasas de espectro extendido en la comunidad en España: un estudio transversal y metaanálisis
Visits
166
Gerard Munté Muñiza,b, Inmaculada Lopez Montesinosa,b, Eduardo Padilla Leónd, Aida Esperanza Ramírez Marinerod, Milagro Monteroa,b,c,f, Luisa Sorlia,b,c,f, Xavier Duran Jordae, Juan P. Horcajadaa,b,c,f,
Corresponding author
jhorcajada@psmar.cat

Corresponding author.
a Hospital del Mar, Barcelona, Spain
b Hospital del Mar Research Institute (IMIM), Barcelona, Spain
c Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), Barcelona, Spain
d Laboratori de Referència de Catalunya (LRC), Barcelona, Spain
e Statistics Department, Hospital del Mar Research Institute (IMIM), Barcelona, Spain
f Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (4)
Table 1. Sequence type (ST) and resistome of 14 ESBL-E. coli/K. pneumoniae strains isolated.
Table 2a. Descriptive characteristics of faecal carriers of the ESBL-producing or CIP or SXT resistant bacteria vs non-carriers.
Table 2b. Descriptive characteristics of faecal carriers of each type of resistance (ESBL-producing or resistance to CIP or SXT) vs non-carriers.
Table 3. Multivariate analysis models of risk factors for different antimicrobial resistance profiles.
Show moreShow less
Additional material (1)
Abstract
Objectives

To determine the prevalence of and risk factors for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) faecal carriage among healthy volunteers from Barcelona, and to estimate the pooled prevalence in the community in Spain.

Methods

University students were asked to complete a questionnaire and provide a rectal swab, which was tested for ESBL-producing, ciprofloxacin- and trimethoprim–sulfamethoxazole-resistant Enterobacterales. Risk factors for carriage of antimicrobial resistance were identified by multivariate logistic regression. To place these results in the appropriate context, a systematic literature search was conducted to retrieve articles containing data on the prevalence of ESBL-PE faecal carriage in the community in Spain. To obtain the pooled prevalence, a random-effects meta-analysis was performed.

Results

One hundred and thirty-five of 214 participants were included in the analysis. Faecal carriage of Escherichia coli/Klebsiella pneumoniae (E/K) resistant to at least one of the antibiotics tested was found in 32 participants (23.7%). Fourteen subjects carried ESBL-E/K (10.4%), with the CTX-M type being the most prevalent (85.7%). Risk factors for ESBL carriage were travel to a high-risk region in the past 3 years (OR 5.66; 95% CI 1.07–29.9) and living in a crowded city district (OR 6.91; 95% CI 1.22–39.08). Thirteen articles covering 21,760 individuals from Spain were included in the meta-analysis, giving a pooled prevalence rate for ESBL-PE carriage in the community of 5.8% (95% CI 4.1–7.8%), and a steady increase per year.

Conclusions

The faecal colonisation prevalence by ESBL-PE among healthy individuals in Spain is high. It is associated with international travel and living in crowded city districts.

Keywords:
Extended-spectrum beta-lactamase (ESBL)
Prevalence
Risk factors
Community
Healthy population
Meta-analysis
Resumen
Objetivos

Determinar la prevalencia y los factores de riesgo de la colonización fecal por ESBL-PE entre voluntarios sanos de Barcelona, así como estimar la prevalencia en la comunidad en España.

Métodos

Estudiantes universitarios completaron un cuestionario y proporcionaron un frotis rectal, que fue analizado para detectar Enterobacterales productores de betalactamasas de espectro extendido (BLEE-PE) y resistentes a ciprofloxacino y a trimetoprima-sulfametoxazol. Los factores de riesgo se identificaron mediante regresión logística multivariada. Para situar estos resultados en el contexto adecuado, se realizó una búsqueda sistemática de la literatura para recuperar artículos con datos sobre la prevalencia de la colonización fecal por BLEE-PE en la comunidad en España. Para obtener la prevalencia combinada, se realizó un metaanálisis de efectos aleatorios.

Resultados

Ciento treinta y cinco de los 214 participantes fueron incluidos en el análisis. Se encontró colonización fecal de E. coli/K. pneumoniae (E/K) resistente a al menos uno de los antibióticos analizados en 32 participantes (23,7%). Catorce sujetos portaban BLEE-E/K (10,4%), siendo el tipo CTX-M el más prevalente (85,7%). Los factores de riesgo para la colonización por BLEE fueron viajar a una región de alto riesgo en los últimos 3 años (OR: 5,66; IC 95%: 1,07-29,9) y vivir en un distrito urbano densamente poblado (OR: 6,91; IC 95%: 1,22-39,08). En el metaanálisis se incluyeron 13 artículos que abarcaban a 21.760 individuos de España, resultando una tasa de prevalencia combinada de colonización por BLEE-PE en la comunidad del 5,8% (IC 95%: 4,1-7,8%), con un con un aumento anual constante.

Conclusiones

La prevalencia de la colonización fecal por BLEE-PE entre individuos sanos en España es alta. Está asociada con viajes internacionales y vivir en distritos urbanos densamente poblados.

Palabras clave:
Betalactamasas de especto extendido (BLEE)
Prevalencia
Factores de riesgo
Comunidad
Población sana
Metaanálisis

Article

These are the options to access the full texts of the publication Enfermedades Infecciosas y Microbiología Clínica
Member

Socio de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica

Para acceder a la revista

Es necesario que lo haga desde la zona privada de la web de la SEIMC, clique aquí

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Enfermedades Infecciosas y Microbiología Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.eimc.2024.11.005
No mostrar más